Ambey Laboratories Limited IPO
Ambey Laboratories Limited is engaged in the manufacturing of agrochemical products aimed at protecting crops. With nearly four decades of experience in the agrochemical sector, we specialize in producing and supplying “2, 4-D base chemicals.” Their operations are characterized by the highest quality practices and compliance with stringent Environmental, Health, and Safety (EHS) standards in the chemical industry.
Manufacturing Facility and Quality Assurance
Their state-of-the-art manufacturing facility is located in Behror, Rajasthan, spanning 5 acres. The facility is equipped with advanced Programmable Logic Controller (PLC) and Supervisory Control systems, alongside a robust Quality Assurance Department. This department ensures rigorous testing at every stage of production using High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Ultraviolet (UV) spectroscopy, and other methodologies.
Product Range
They manufacture a wide range of agrochemical products, including:
i. 2,4-D Acid 98% TC ii. 2,4-D Sodium 95% SP
iii. 2,4-D Amine 866 | 720 | 480g/l SL iv. 2,4-D Ethyl Hexyl Ester 96% TC
v. 2,4-D Ethyl Ester 96% TC vi. Chlorpyriphos 97%TC / 20%EC / 50%EC
vii. Thiamethoxam 96%TC / 25%WG / 75%SG viii. Pretilachlor 95%TC / 50%EC / 37%EW
ix. Metribuzin 97%TC / 70%WS x. Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC
xi. Metalaxyl 98%TC / 35%WS
Their esteemed customer base includes large corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.
Conclusion
Ambey Laboratories Limited stands as a trusted name in the agrochemical industry, backed by nearly four decades of expertise and a steadfast commitment to quality and environmental sustainability. Their state-of-the-art manufacturing facility, comprehensive product range, and strong client relationships position them as a leader in the market, dedicated to protecting crops and supporting the agricultural sector.
Objects of the Ambey Laboratories Limited IPO:
Ambey Laboratories Limited IPO Details:
Open Date: | Jul 04 2024 |
Close Date: | Jul 08 2024 |
Total Shares: | 6,570,000 |
Face Value: | ₹ 10 Per Equity Share |
Issue Size: | 40.68 Cr. |
Lot Size: | 2000 Shares |
Issue Price: | ₹ 65 - 68 Per Equity Share |
Listing At: | NSE Emerge |
Listing Date: | Jul 11 2024 |
Promoters And Management:
Financials of Ambey Laboratories Limited IPO:
Particulars ( In Lakhs ) |
2021 |
2022 |
2023 |
10M-FY24 |
Revenue from Operations | 8,174 | 8,460 | 10,482 | 10,032 |
Other Income | 68 | 51 | 261 | 12 |
Total Revenue | 8,242 | 8,511 | 10,743 | 10,044 |
Cost of Material Consumed | 6,448 | 6,991 | 9,294 | 8,872 |
Changes in inventory | 188 | -101 | -303 | -519 |
Employees Benefit Expenses | 191 | 195 | 242 | 170 |
Other Expenses | 375 | 341 | 408 | 241 |
EBITDA | 1,041 | 1,085 | 1,103 | 1,279 |
OPM (%) | 12.63% | 12.75% | 10.26% | 12.74% |
Depreciation & Amortisation | 322 | 297 | 296 | 283 |
EBIT | 718 | 788 | 806 | 996 |
Finance Cost | 410 | 305 | 184 | 158 |
PBT | 309 | 483 | 622 | 838 |
Tax | -725 | 126 | 165 | 235 |
PAT | 1034 | 357 | 457 | 603 |
NPM (%) | 12.54% | 4.20% | 4.25% | 6.00% |
No.of Shares | 249.46 | 249.46 | 249.46 | 249.46 |
EPS | 4.14 | 1.43 | 1.83 | 2.41 |
Comparison With Peers:
Name of the Company | Revenue (In Crore) | PAT (In Crore) | EPS ( in Rs) | P/E | CMP | Mcap (In Crore) |
Ambey Laboratories Limited | 105 | 5 | 1.83 | 37.1 | 68 | 170 |
Atul Limited | 5,428 | 507 | 174.19 | 60.1 | 6,586 | 19,389 |
Meghmani Organics Limited | 2,553 | 238 | 9.35 | N/A | 82.7 | 2,104 |
Recommendation on Ambey Laboratories Limited IPO:
Lead Manager of Ambey Laboratories Limited IPO:
Registrar of Ambey Laboratories Limited IPO:
Company Address:
Discussion on Ambey Laboratories Limited IPO:
Leave a Reply
You must be logged in to post a comment.